Gastric Varices from Metastatic Ovarian Cancer with Splenic Involvement
Total Page:16
File Type:pdf, Size:1020Kb
A CASE REPORT A CASE REPORT Gastric Varices from Metastatic Ovarian Cancer with Splenic Involvement by Allyce Caines, Ghassan Allo, Yousuf Siddiqui Left-sided portal hypertension (LSPH), also known as splenoportal hypertension, is a rare but life-threatening cause of upper gastrointestinal bleeding. LSPH often occurs in non-cirrhotic patients as a consequence of splenic vein obstruction. We present a case of isolated gastric varices due to mass effect on the splenic vein and likely tumor thrombus due to metastatic ovarian cancer. INTRODUCTION ortal hypertension refers to increased pressures formation or mass effect, are the most common in the hepatic portal system. This in turn leads causes of LSPH. These patients often have no Pto complications such as variceal hemorrhage known prior liver disease and have no evidence from gastric or esophageal varices, ascites and of cirrhosis on presentation. Bleeding can be hepatic encephalopathy. Upper gastrointestinal catastrophic due to high portal pressures. In these bleeding secondary to portal hypertension in the cases, it is important to consider causes of left sided form of variceal hemorrhage is a recognized life- portal hypertension and the available treatment threatening cause of gastrointestinal bleeding. options. In patients with gastrointestinal bleeding due to portal hypertension, bleeding from gastric varices Case Report is the cause in 5%-10% of patients.1 Increased A 59 year-old female with a past medical history resistance to portal flow due to a stiff, cirrhotic liver of metastatic ovarian cancer and obstructive is often the cause of portal hypertension. However, uropathy, secondary to extrinsic compression, portal hypertension can also be caused by isolated presented to her primary gynecologic oncologist obstruction of the splenic vein, which is often with complaints of fatigue, lightheadedness and referred to left sided portal hypertension (LSPH). melena for one week. On laboratory evaluation, LSPH accounts for less than 5% of all patient with she was found to have a hemoglobin of 5.7 g/dL portal hypertension1. Most of the reported cases prompting emergency evaluation. Four years prior of splenic vein obstruction have been the result she was diagnosed with stage IIIC serous carcinoma of malignancy involving the spleen. Pancreatic of the ovary, at which time she underwent total disorders, including pancreatic carcinoma, acute abdominal hysterectomy, omentectomy, pelvic and chronic pancreatitis, cysts, and pseudocysts lymphadenectomy, tumor debulking and subtotal which may block the splenic vein via thrombus colectomy with diverting ileostomy followed Allyce Caines, MD1 Ghassan Allo, MD1 Yousuf Siddiqui, MD1 1Henry Ford Health System, Gastroenterology, Detroit, MI 40 PRACTICALGASTROENTEROLOGY • FEBRUARY2020 Gastric Varices from Metastatic Ovarian Cancer with Splenic Involvement A CASE REPORT A CASE REPORT by chemotherapy. She remained disease free for Repeat endoscopy confirmed the findings of type approximately nine months when imaging showed 1 isolated gastric varices with red wale signs disease recurrence. She developed significant (Figure 2). disease progression involving the splenic hilum, BRTO, splenectomy, gastric vessel ligation and retroperitoneal lymph nodes and pelvis in addition cyanoacrylate injection were discussed as potential to bilateral hydronephrosis. therapeutic options. The patient had no further On presentation to the emergency department episodes of bleeding and her hemoglobin remained she was hemodynamically stable with unremarkable stable. Magnetic resonance imaging (MRI) physical exam. An episode of hematemesis revealed a hypovascular mass in the splenic hilum consisting of 500cc of bright red blood occurred in with minimal central enhancement concerning the emergency department with repeat hemoglobin for metastatic disease. Areas of hypovascular of 4.5 g/dL. Endoscopy revealed type 1 isolated nodularity around the lesion extending into part gastric varices (IGV1). She received a total of 6 of the splenic vein at the hilum and branches units of packed red blood cells. The patient was were suggestive of tumor thrombus. Liver lesions then transferred for consideration of balloon concerning for metastatic disease were also present. retrograde transvenous obliteration (BRTO). On MRI the hepatic vein, celiac artery, hepatic Figure 1. A. Tumor within splenic hilum. Inset 5 cm B. Poorly differentiated carcinoma within spleen. Hematoxylin and Eosin. 20X C. Poorly differentiated carcinoma within spleen. Hematoxylin and Eosin. 100X D. Estrogen receptor (ER) immunohistochemistry. 100X PRACTICALGASTROENTEROLOGY • FEBRUARY2020 41 Gastric Varices from Metastatic Ovarian Cancer with Splenic Involvement A CASE REPORT Figure 2. Type 1 isolated gastric varices with red wale signs artery, portal vein and superior mesenteric vein as well as likely tumor thrombus caused splenic were patent. The splenic artery appeared tortuous venous outflow obstruction. Obstruction of the and the splenic vein was engorged. splenic vein results in venous hypertension in The patient was not a candidate for BRTO collateral pathways that carry splenic arterial blood due to the lack of portosystemic collaterals. via the short gastric, coronary, and gastroepiploic She underwent splenic artery embolization to veins to the superior mesenteric and portal veins. decrease inflow to the spleen and splenectomy In the gastric wall veins of the fundus, blood flow the following day. Pathology revealed a 4.4 x and pressure increase, and submucosal structures 3.7 x 3.1 cm ill-defined mass located within the consequently dilate, producing gastric varices.4,3 splenic hilum (Figure 1A), which consisted of Risk factors for gastric variceal hemorrhage poorly differentiated adenocarcinoma (Figure 1B- include the size of fundal varices (as there is a 1C). Immunohistochemically, the adenocarcinoma linear relationship between size of varices and risk was positive for cytokeratin AE1/AE3, CK7, of variceal hemorrhage), endoscopic presence of PAX-8 and estrogen receptor (Figure 1D). The variceal red spots, and Child-Pugh class in patients adenocarcinoma was negative for CK20. The with cirrhosis.5 Gastric varices are less frequent morphology and immunohistochemistry were than esophageal varices and are present in 5%- consistent with metastatic adenocarcinoma of 33% of patients with portal hypertension. The müllerian origin, from the patient’s known ovarian reported incidence of bleeding from gastric varices adenocarcinoma. is approximately 25% in two years, with a higher bleeding incidence for fundal varices.6 Compared Discussion to esophageal varices, gastric varices are larger, LSPH, also known as splenoportal or sinistral more extensive, and lie deeper in the submucosa. hypertension is a rare, but life-threatening cause As a result, standard endoscopic treatments for of upper gastrointestinal bleeding.2 LSPH often esophageal varices, including band ligation and occurs in non-cirrhotic patients as a consequence sclerotherapy are largely ineffective for gastric of splenic vein obstruction. Pancreatic disorders, varices.7 including pancreatic carcinoma, acute and chronic Management of gastric varices is dependent pancreatitis, cysts, and pseudocysts which may on the etiology, presence of collaterals and the block the splenic vein via thrombus formation or available treatment modalities. LSPH, for example, mass effect, are the most common causes of LSPH.3 has distinct therapeutic management options that are To our knowledge there is only one other case of not appropriate for the management of generalized LSPH with bleeding gastric varices secondary to portal hypertension. Currently the gold standard for metastatic ovarian cancer published by Wallace treatment of fundal (IGV1) varices as a result of et al in 2004.4 splenic vein thrombosis is splenectomy. Surgical In our case, mass effect on the splenic vein (continued on page 44) 42 PRACTICALGASTROENTEROLOGY • FEBRUARY2020 Gastric Varices from Metastatic Ovarian Cancer with Splenic Involvement A CASE REPORT (continued from page 42) 3. Koklu S, Yuksel O, Arhan M, et al. Report of 24 left- removal of the spleen decreases venous outflow sided portal hypertension cases: a single-center pro- through collateral circulations and decompresses spective cohort study. Dig Dis Sci. 2005;50:976-82. IGV to prevent future bleeding.8 Additional therapies 4. Koklu S, Coban S, Yuksel O, Arhan M. Left-Sided have been used to control gastric variceal bleeding Portal Hypertension. Dig Dis Sci. 2007; 52: 1141- and prevent re-bleeding from occurring. These 1149. 5. Garcia-Tsao G, Sanyal AR, Grace ND, Carey W. include band ligation and endoscopic sclerotherapy AASLD Practice Guidelines: Prevention and (frequently by cyanoacrylate glue injection). The Management of Gastroesopahgeal Varices and Variceal American Association for the Study of Liver Hemorrhage in Cirrhosis. Hepatology. 2007; Vol Diseases (AASLD) Society guidelines recommend 46(3). endoscopic variceal sclerotherapy in patients 6. Moosa AR, Gadd MA. Isolated splenic vein thrombo- who bleed from gastric fundal varices otherwise sis. World J Surg. 1985;9: 384-90. 7. Wallace W, Mulholland K, Epanomeritakis E. when available, endoscopic variceal ligation is an Bleeding Gastric Varices – A Rare Complication of option. AASLD also recommends that transjugular Ovarian Cancer. Int J Clin Pract. 2005; 59: 119-120. intrahepatic portosystemic shunt (TIPS) should be 8. Bernades P, Baetz A, Levy P, et al: Splenic and portal considered